DEUTSCHE BANK AG\ - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 55 filers reported holding AKERO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,594,098
-31.4%
110,599
-36.6%
0.00%0.0%
Q2 2023$8,149,739
-59.0%
174,550
-66.4%
0.00%
-63.6%
Q1 2023$19,878,940
-15.2%
519,575
+21.5%
0.01%
-15.4%
Q4 2022$23,437,028
+5312.7%
427,683
+3260.7%
0.01%
Q3 2022$433,000
+211.5%
12,726
-13.8%
0.00%
Q2 2022$139,000
-40.6%
14,763
-10.7%
0.00%
Q1 2022$234,000
-39.1%
16,531
-9.0%
0.00%
Q4 2021$384,000
-53.5%
18,171
-50.8%
0.00%
Q3 2021$826,000
-12.5%
36,967
-2.8%
0.00%
Q2 2021$944,000
+8.0%
38,045
+26.3%
0.00%
Q1 2021$874,000
-48.7%
30,129
-54.4%
0.00%
-100.0%
Q4 2020$1,704,000
-53.9%
66,055
-45.0%
0.00%
-66.7%
Q3 2020$3,695,000
+161.5%
119,991
+111.6%
0.00%
+200.0%
Q2 2020$1,413,000
+2378.9%
56,714
+1996.6%
0.00%
Q1 2020$57,000
+54.1%
2,705
+60.0%
0.00%
Q4 2019$37,000
+27.6%
1,691
+28.4%
0.00%
Q3 2019$29,0001,3170.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Skorpios Trust 1,621,829$75,723,19632.88%
COMMODORE CAPITAL LP 1,675,000$78,205,7508.79%
Ghost Tree Capital, LLC 360,000$16,808,4005.55%
Boxer Capital, LLC 1,676,733$78,2873.63%
SILVERARC CAPITAL MANAGEMENT, LLC 241,357$11,268,9583.49%
Atlas Venture Life Science Advisors, LLC 594,251$27,745,5793.45%
SILVERARC CAPITAL MANAGEMENT, LLC 236,500$11,039,8203.42%
Logos Global Management LP 520,000$24,278,8003.30%
Redmile Group, LLC 1,811,672$84,586,9663.25%
Yiheng Capital Management, L.P. 1,201,591$56,102,2843.03%
View complete list of AKERO THERAPEUTICS INC shareholders